JNJ-55511118

JNJ-55511118

Biochem/physiol Actions

JNJ-55511118 is an orally available, brain penetrant, potent and selective negative modulator of AMPA receptors that requires the presence of the accessory protein CACNG8 (TARP-γ8). JNJ-55511118 exhibit potent inhibition of neurotransmission within hippocampus, and a strong anti-convulsant effect.

JNJ-55511118 is also known as 5-[2-chloro-6-(trifluoromethoxy)phenyl]-1,3-dihydrobenzimidazol-2-one. It acts as an anticonvulsant or neuroprotectant. It is considered as a reversible ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor inhibitor, mainly in the hippocampus region.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575340 JNJ-55511118 white to beige 100 SIGMA-ALDRICH 2-8°C DMSO: 25 mg/mL, clear powder ≥98% (HPLC)
£604.50 (exc VAT) per 25MG
-
+
3575341 JNJ-55511118 white to beige 100 SIGMA-ALDRICH 2-8°C DMSO: 25 mg/mL, clear powder ≥98% (HPLC)
£149.04 (exc VAT) per 5MG
-
+